Can unscheduled inpatient length of stay and hospital costs be reduced using 'flash' glucose monitoring? - Trial ISRCTN11565460
Access comprehensive clinical trial information for ISRCTN11565460 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of the Highlands and Islands and is currently status unknown. The study focuses on Diabetes mellitus. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ISRCTN Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of the Highlands and Islands
Interreg
Timeline & Enrollment
Phase 2
Oct 14, 2019
Jan 31, 2022
Summary
Can unscheduled inpatient length of stay and hospital costs be reduced using โFlashโ glucose monitoring?
ICD-10 Classifications
Data Source
ISRCTN Registry
ISRCTN11565460
Device Trial

